pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

23,077 catalysts · 4,900 device 510k · 4,728 grant · 3,532 approval · 3,126 8k filing · 2,000 device pma · 2,000 device recall

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 19 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 2 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2024-10-08×clear all
type
  • device 510k4,900
  • grant4,728
  • approval3,532
  • 8k filing3,126
  • device pma2,000
  • device recall2,000
  • recall1,126
  • device adverse event1,000
  • earnings583
  • phase 2 completion172
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Oct 28, 2024

    50
    ›Oct 29, 2024device 510k652d agoAtriCure, Inc. — AtriCure cryoICE BOX (ACM) (510k cleared)AtriCure, Inc.

    Product code: GXH. Advisory committee: Neurology. Type: Special

    full page →fda device 510k ↗
    ›Oct 29, 2024device 510k652d agoRiverpoint Medical — OC JuggerKnotless Soft Anchor; OC JuggerLoop Soft Anchor (510k cleared)

    Product code: MBI. Advisory committee: Orthopedic. Type: Special

    full page →fda device 510k ↗
    ›Oct 29, 2024device 510k652d agoQIAGEN GmbH — QIAstat-Dx Meningitis/Encephalitis (ME) Panel (510k cleared)

    Product code: PLO. Advisory committee: Microbiology. Type: Traditional

    full page →fda device 510k ↗
    ›Oct 29, 2024device 510k652d agoTigon Medical — Tigon Medical Fractures, Instability, and Reconstruction (FIRE) (510k cleared)

    Product code: HWC. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Oct 29, 2024device 510k652d agoZimmer, Inc. — Persona the Personalized Knee System (510k cleared)

    Product code: MBH. Advisory committee: Orthopedic. Type: Special

    full page →fda device 510k ↗
    ›Oct 29, 2024device 510k652d agoVarian Medical Systems — Catheter Surface Flap Applicator Set (GM11011830) (510k cleared)

    Product code: JAQ. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Oct 29, 2024device 510k652d agoJiaxing Xiaoxiang Medical Equipment Technology Co., Ltd. — Electric Wheelchair (ME23-EW16-BC200-01); Electric Wheelchair (ME23-EW16-BC200-02) (510k cleared)

    Product code: ITI. Advisory committee: Physical Medicine. Type: Traditional

    full page →fda device 510k ↗
    ›Oct 29, 2024device 510k652d agoNovatech SA — TRACHEOBRONXANE™ DUMON® (510k cleared)Novatech SA

    Product code: NWA. Advisory committee: General, Plastic Surgery. Type: Special

    full page →fda device 510k ↗
    ›Oct 29, 2024device 510k652d agoDegen Medical — DeGen Medical Patient Specific Implant (PSI) System (510k cleared)

    Product code: OVD. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Oct 30, 2024approval651d agoBRIUMVI (UBLITUXIMAB-XIIY) — FDA approvalublituximab

    Sponsor: TG THERAPEUTICS, INC. Form: INJECTABLE. Route: INTRAVENOUS

    full page →ublituximab →fda approvals ↗
    ›Oct 30, 2024approval651d agoCABLIVI (CAPLACIZUMAB-YHDP) — FDA approvalGenzyme Corp

    Sponsor: ABLYNX NV. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Oct 30, 2024approval651d agoHYDROMORPHONE HYDROCHLORIDE — FDA approvalSpecGx LLC

    Sponsor: OSMOTICA PHARM US. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Oct 30, 2024recall651d agoFresenius Kabi Compounding, LLC recall (Cls II)Baxter Healthcare Corp

    NORepinephrine Bitartrate 0.9% Sodium Chloride Injection USP, 8 mg per 250 mL, Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC: 71506-027-58 — Reason: cGMP violations — Status: Terminated

    full page →fda recalls ↗
    ›Oct 30, 2024recall651d agoFresenius Kabi Compounding, LLC recall (Cls II)Revalesio Corp

    Phenylephrine HCl 0.9% Sodium Chloride Injection USP, 10 mg per 250 mL, Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC 71506-010-58 — Reason: cGMP violations — Status: Terminated

    full page →fda recalls ↗
    ›Oct 30, 2024recall651d agoFresenius Kabi Compounding, LLC recall (Cls II)Revalesio Corp

    EPINEPHrine 0.9% Sodium Chloride Injection USP, 8 mg per 250 mL Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC: 71506-060-58 — Reason: cGMP violations — Status: Terminated

    full page →fda recalls ↗
    ›Oct 30, 2024recall651d agoFresenius Kabi Compounding, LLC recall (Cls II)Revalesio Corp

    Oxytocin 0.9% Sodium Chloride Injection USP, 30 units per 500 mL Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC: 71506-028-59 — Reason: cGMP violations — Status: Terminated

    full page →fda recalls ↗
    ›Oct 30, 2024recall651d agoC & A Naturistics recall (Cls II)IGC Pharma, Inc.

    AK Forte Ortiga y Omega 3 Cont. Neto 100 Tabletas, 400 mg, — Reason: Marketed without an Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared diclofenac and acetaminophen. — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 30, 2024recall651d agoFresenius Kabi Compounding, LLC recall (Cls II)Baxter Healthcare Corp

    NORepinephrine Bitartrate 0.9% Sodium Chloride Injection USP, 4 mg per 250 mL, Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC: 71506-025-58 — Reason: cGMP violations — Status: Terminated

    full page →fda recalls ↗
    ›Oct 30, 2024recall651d agoAkron Pharma, Inc. recall (Cls II)aTYR PHARMA INC

    OneLAX Docusate Sodium Liquid (docusate sodium 50 mg/5 mL) Stool Softener Laxative, 16 FL OZ (473 mL) bottle, Akron Pharma, Manufactured for: Akron Pharma, Inc., Fairfield, NJ 07004, NDC 71399-0039-06. — Reason: CGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 30, 2024recall651d agoFresenius Kabi Compounding, LLC recall (Cls II)Revalesio Corp

    Phenylephrine HCl 0.9% Sodium Chloride Injection USP, 20 mg per 250 mL, Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC 71506-024-58 — Reason: cGMP violations — Status: Terminated

    full page →fda recalls ↗
    ›Oct 30, 2024recall651d agoFresenius Kabi Compounding, LLC recall (Cls II)Revalesio Corp

    Thiamine HCl 0.9% Sodium Chloride Injection USP, 500 mg per 100 mL, Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC: 71506-079-56 — Reason: cGMP violations — Status: Terminated

    full page →fda recalls ↗
    ›Oct 30, 2024recall651d agoFresenius Kabi Compounding, LLC recall (Cls II)Revalesio Corp

    Vancomycin HCl 750 mg per 250 mL 0.9% Sodium Chloride Injection USP, Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC 71506-014-58 — Reason: cGMP violations — Status: Terminated

    full page →fda recalls ↗
    ›Oct 30, 2024recall651d agoFresenius Kabi Compounding, LLC recall (Cls II)Revalesio Corp

    Phenylephrine HCl 0.9% Sodium Chloride Injection USP, 20 mg per 250 mL, Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC 71506-002-58 — Reason: CGMP violations — Status: Terminated

    full page →fda recalls ↗
    ›Oct 30, 2024recall651d agoFresenius Kabi Compounding, LLC recall (Cls II)Revalesio Corp

    Phenylephrine HCl 0.9% Sodium Chloride Injection USP, 10 mg per 250 mL, Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC 71506-029-58 — Reason: cGMP violations — Status: Terminated

    full page →fda recalls ↗
    ›Oct 30, 2024device 510k651d agoNeuraxis — NeurAxis IB-Stim (01-1020) (510k cleared)Neuraxis, INC

    Product code: QHH. Advisory committee: Gastroenterology, Urology. Type: Traditional

    full page →fda device 510k ↗
    ›Oct 30, 2024device 510k651d agoIde Vision, Ltd. — MedicCO2LON (MedicCO2LON) (510k cleared)Rail Vision Ltd.

    Product code: FCX. Advisory committee: Gastroenterology, Urology. Type: Traditional

    full page →fda device 510k ↗
    ›Oct 30, 2024device 510k651d agoiRhythm Technologies, Inc. — Zio AT® device (A100A1001) (510k cleared)TTM TECHNOLOGIES INC

    Product code: DSI. Advisory committee: Cardiovascular. Type: Traditional

    full page →fda device 510k ↗
    ›Oct 30, 2024device 510k651d agoRemedy Logic, Inc. — RemedyLogic AI MRI Lumbar Spine Reader (510k cleared)

    Product code: QIH. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Oct 30, 2024device 510k651d agoSonomotion, Inc. — Stone Clear (SC-LP9-01) (510k cleared)

    Product code: QNA. Advisory committee: Gastroenterology, Urology. Type: Direct

    full page →fda device 510k ↗
    ›Oct 30, 2024device 510k651d agoSiemens Medical Solutions USA, Inc. — Symbia Pro.specta Q3 (11364751); Symbia Pro.specta X3 (11364752); Symbia Pro.specta X7 (11364753); Symbia Pro.specta VA30A Family (510k cleared)

    Product code: KPS. Advisory committee: Radiology. Type: Special

    full page →fda device 510k ↗
    ›Oct 30, 2024device 510k651d agoMicrogenics Corporation — DRI Ecstasy Plus Assay (510k cleared)

    Product code: DKZ. Advisory committee: Clinical Toxicology. Type: Special

    full page →fda device 510k ↗
    ›Oct 30, 2024device 510k651d agoGuangdong Genial Technology Co., Ltd. — Wearable Digital Thermometer (T31) (510k cleared)

    Product code: FLL. Advisory committee: General Hospital. Type: Traditional

    full page →fda device 510k ↗
    ›Oct 30, 2024device 510k651d agoSmith & Nephew, Inc. — JOURNEY II Unicompartmental Knee System (JOURNEY II UK) (510k cleared)SMITH & NEPHEW PLC

    Product code: HSX. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Oct 30, 2024device 510k651d agoIzenimplant Co., Ltd. — ZENEX Implant System_Long (510k cleared)

    Product code: DZE. Advisory committee: Dental. Type: Traditional

    full page →fda device 510k ↗
    ›Oct 30, 2024device 510k651d agoHistoSonics, Inc. — Edison System (510k cleared)

    Product code: QGM. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Oct 30, 2024device 510k651d agoNingbo Medsun Medical Co., Ltd. — Safety Lancet (510k cleared)

    Product code: FMK. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Oct 30, 2024device 510k651d agoTaiwan Main Orthopaedic Biotechnology Co., Ltd. — Caduceus S (510k cleared)

    Product code: SBF. Advisory committee: Neurology. Type: Traditional

    full page →fda device 510k ↗
    ›Oct 30, 2024device 510k651d agoLagis Enterprise Co., Ltd. — LAGIS Endoscopic Instruments - Grasper (DI-5670-33D, DI-5670-45D, DI-5716-33D, DI-5716-45D, DI-5719-33D, DI-5731-33D, DI-5731-45D, DI-5901-33D, DI-5901-45D) (510k cleared)Cre8 Enterprise Ltd

    Product code: GCJ. Advisory committee: Gastroenterology, Urology. Type: Traditional

    full page →fda device 510k ↗
    ›Oct 31, 2024approval650d agoTRAMADOL HYDROCHLORIDE — FDA approvaltramadol hydrochloride ER

    Sponsor: STRIDES PHARMA. Form: TABLET. Route: ORAL

    full page →tramadol hydrochloride ER →fda approvals ↗
    ›Oct 31, 2024approval650d agoNICARDIPINE HYDROCHLORIDE — FDA approvalNICARDIPINE HYDROCHLORIDE

    Sponsor: AMNEAL. Form: INJECTABLE. Route: INJECTION

    full page →NICARDIPINE HYDROCHLORIDE →fda approvals ↗
    ›Oct 31, 2024approval650d agoTRAMADOL HYDROCHLORIDE — FDA approvalTrigen Laboratories Inc

    Sponsor: UNICHEM. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Oct 31, 2024approval650d agoNALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE) — FDA approvalnaloxone hydrochloride

    Sponsor: LUPIN. Form: TABLET. Route: ORAL

    full page →naloxone hydrochloride →fda approvals ↗
    ›Oct 31, 2024approval650d agoMETHADONE HYDROCHLORIDE — FDA approvalMETHADONE HYDROCHLORIDE

    Sponsor: VISTAPHARM LLC. Form: SOLUTION. Route: ORAL

    full page →METHADONE HYDROCHLORIDE →fda approvals ↗
    ›Oct 31, 2024approval650d agoOXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalIGC Pharma, Inc.

    Sponsor: NOVEL LABS INC. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Oct 31, 2024approval650d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalIGC Pharma, Inc.

    Sponsor: NOVEL LABS INC. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Oct 31, 2024approval650d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

    Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

    full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
    ›Oct 31, 2024approval650d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

    Sponsor: VISTAPHARM LLC. Form: SOLUTION. Route: ORAL

    full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
    ›Oct 31, 2024approval650d agoOXYCODONE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: NOVEL LABS INC. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Oct 31, 2024approval650d agoOXYMORPHONE HYDROCHLORIDE — FDA approvalOXYMORPHONE HYDROCHLORIDE

    Sponsor: ACTAVIS ELIZABETH. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →OXYMORPHONE HYDROCHLORIDE →fda approvals ↗
    ›Oct 31, 2024approval650d agoHYDROCODONE BITARTRATE AND ASPIRIN (ASPIRIN) — FDA approvalPurdue Pharma LP

    Sponsor: LGM PHARMA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ← prev
    page 6 of 462
    next →
    $ATRC
    $RVSN4.4000-4.56%
    $IGC0.2670+0.41%
    $TGTX49.90+1.51%
    $AMRX17.10-4.36%
    $NRXS
    $TTMI
    $SNN30.01-0.23%
    $ATYR
    $CRE
    $AMRX17.10-4.36%
    $IGC0.2670+0.41%
    $IGC0.2670+0.41%